RALEIGH, N.C., Jan. 29, 2026 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Addyi (R) has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of ...

Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...

The FDA has approved Addyi (flibanserin), a nonhormonal daily pill, to treat low libido in women through age 65. The FDA previously approved Addyi for low sex drive in younger women. Addyi carries a ...

The FDA expanded its approval of Addyi, a pill to treat low libido in women, to include postmenopausal women up to age 65. The approval will open up new treatment options for older women, but experts ...

WASHINGTON — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by postmenopausal women up to 65 years old ...

A new documentary, 'The Pink Pill: Sex, Drugs and Who Has Control,' explores the fight to bring the women’s sexual health pill, Addyi, to market Addyi; Catalyst Works The new documentary, The Pink ...

Ten years since the landmark approval of the first and only FDA-authorized pill clinically proven to treat low libido in women, Sprout Pharmaceuticals CEO Cindy Eckert reflects on advancements and ...

CLEVELAND — The Food and Drug Administration has approved expanded use of Addyi, a medication designed to address low sexual desire in women, now including post-menopausal women under age 65. Sprout ...

Like a woman’s libido, the name of the new drug approved to treat female sexual dysfunction is hard to understand—let alone pronounce. Yes, as if women struggling with hypoactive sexual desire ...

Sprout Pharmaceuticals today announced that Addyi® has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of the most trusted and influential honors a brand ...